Trial
NCT00353379
Pharmacology of Cognition in Schizotypal Personality Disorder
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Institute of Mental Health (NIMH)
Condition
Schizotypal Personality Disorder
Intervention
Guanfacine
Why stopped
low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-10